Current treatment strategies in small cell lung cancer
The objective of our study was to evaluate the comparative effectiveness of different treatment regimens small cell cancer patients. The study included 86 patients (22 (25,6%) were women, 64 (74,4%) - males, mean age 62 ± 4,87 years), divided by 2 groups: group 1 - 46 (53,4%) people with limited-stage disease, group 2 - 40 (46,6%)patients with extensive-stage disease. The results of the study showed that surgical treatment followed by adjuvant chemotherapy in patients with with limited-stage disease A-IIA and IIB stage significant improved three-year survival rates, compared with chemotherapy alone. Chemoradiotherapy in patients with extensive-stage disease significantly increases one-and two-year survival rates, partial response and stability of disease, compared to the chemotherapy alone.